Neuropeptide Y 3-36 is an endogenous ligand selective for Y2 receptors

Regulatory Peptides

Volumn 67, Issue 1, 1996, Pages 33-37

  Grandt, D ^a   Schimiczek, M ^a   Rascher, W ^b   Feth, F ^a   Shively, J ^c   Lee, T D ^c   Davis, M T ^c   Reeve Jr , J R ^d   Michel, M C ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain; HPLC; Molecular heterogeneity; Neuropeptide Y; Neurotransmitter; Pig; Radioimmunoassay; Receptor

Indexed keywords

NEUROPEPTIDE Y DERIVATIVE; NEUROPEPTIDE Y RECEPTOR;

ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; RADIOIMMUNOASSAY; SWINE;

ANIMALS; BINDING, COMPETITIVE; BRAIN; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; NEUROPEPTIDE Y; PEPTIDE FRAGMENTS; PROTEIN BINDING; RECEPTORS, NEUROPEPTIDE Y; SEQUENCE ANALYSIS; SWINE;

ANIMALIA; SUIDAE; SUS SCROFA;

EID: 0030583722     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(96)00104-8     Document Type: Article

References (23)

1. Wahlestedt C., Grundemar L., Hakanson R., Heilig M., Shen G.H., Zukowska Grojec Z., Reis D.J. Neuropeptide Y receptor subtypes, Y1 and Y2. Ann. NY Acad. Sci. 611:1990;7-26.
2. Tatemoto K., Carlquist M., Mutt V. Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature. 296:1982;659-660.
3. Tatemoto K. Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. Proc. Natl. Acad. Sci. USA. 79:1982;2514-2518.
4. Tatemoto K. Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc. Natl. Acad. Sci. USA. 79:1982;5485-5489.
5. Kimmel J., Hayden L., Pollock H. Isolation and characterization of a new pancreatic polypeptide hormone. J. Biol. Chem. 24:1975;9369-9376.
6. Larhammar D., Blomqvist A.G., Soderberg C. Evolution of neuropeptide Y and its related peptides (review). Comp. Biochem. Physiol. C. Comp. Pharmacol. Toxicol. 106:1993;743-752.
7. Michel M.C. Receptors for neuropeptide Y: Multiple subtypes and multiple second messengers. Trends Pharmacol. Sci. 12:1991;389-394.
8. Eysselein V.E., Eberlein G.A., Grandt D., Schaeffer M., Zehres B., Behn B., Schaefer D., Goebell H., Davis M., Lee D.L., Shively J.E., Meyer H.E., Reeve J.R.J. Structural characterization of canine PYY. Peptides. 11:1990;111-116.
9. Eberlein G.A., Eysselein V.E., Schaeffer M., Layer P., Grandt D., Goebell H., Niebel W. A new molecular form of PYY: structural characterization of human PYY(3-36) and PYY(1-36). Peptides. 10:1989;797-803.
10. Grandt D., Teyssen S., Schimiczek M., Reeve J.R. Jr., Feth F., Rascher W., Hirche H., Singer M.V., Layer P., Goebell H. Novel generation of hormone receptor specificity by amino terminal processing of peptide YY. Biochem. Biophys. Res. Commun. 186:1992;1299-1306.
11. Shaw C., Cormican K., Thim L., Maule A.G., Sloan J.M., Buchanan K.D. Neuropeptide Y and neuropeptide Y 3-36; isolation from human pancreatic endocrine tumours. Regul. Pept. 45:1993;387-394.
12. Hunter W.M., Greenwood F.C. Preparation of iodine-131 labelled human growth hormone of high specifity. Nature. 194:1962;495-496.
13. Shively J.E. Sequence determination of proteins and peptides at the nanomoles and subnanomole level using a modified spinning cup sequencer. Methods Enzymol. 79:1981;31-48.
14. Hawke D., Yuan P.M., Shively J.E. Separation of amino acid phenylthiohydantoin derivatives by high performance liquid chromatography on octasilane supports. Anal. Biochem. 120:1982;302-311.
15. De Pauw E., Pelzer G., Dao Viet D., Marien J. On the influence of hydrophobicity in the SIMS spectra of amino acids in glycerol matrix. Biochem. Biophys. Res. Commun. 123:1984;27-32.
16. 1-like neuropeptide Y receptors in SK-N-MC cells, Naunyn-Schmiedeberg's Arch. Pharmacol. 344:1991;1-7.
17. Grandt D., Schimiczek M., Beglinger C., Layer P., Goebell H., Eysselein V.E., Reeve J.R. Jr. Two molecular forms of Peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul. Pept. 51:1994;151-159.
18. Leiter A.B., Toder A., Wolfe H.J., Taylor I.L., Cooperman S., Mandel G., Goodman R.H. Peptide YY. Structure of the precursor and expression in exocrine pancreas. J. Biol. Chem. 262:1987;12984-12988.
19. Mentlein R. Proline residues in the maturation and degradation of peptide hormones and neuropeptides. FEBS Lett. 234:1988;251-256.
20. Mentlein R., Dahms P., Grandt D., Kruger R. Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV. Regul. Pept. 49:1993;133-144.
21. Bongers J., Lambros T., Ahmad M., Heimer E.P. Kinetics of dipeptidyl peptidase IV proteolysis of growth hormone-releasing factor and analogs. Biochim. Biophys. Acta. 1122:1992;147-153.
22. Feth F., Rascher W., Michel M.C. Neuropeptide Y (NPY) receptors in HEL cells: Comparison of binding and functional parameters for full and partial agonists and a non-peptide antagonist. Br. J. Pharmacol. 105:1992;71-76.
23. Fuxe K., Aguirre J.A., Agnati L.F., Von Euler G., Hedlund P., Covenas R., Zoli M., Bjelke B., Eneroth P. Neuropeptide Y and central cardiovascular regulation. Focus on its role as a cotransmitter in cardiovascular adrenergic neurons. Ann. NY Acad. Sci. 611:1990;111-132.